Seizure Medication Articles & Analysis
4 news found
NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for “adjunctive use for reducing the frequency of seizures in individuals 18 years of age or older diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary ...
It is estimated that 1 in 100 people have epilepsy, and 1 in 3 people with epilepsy continue to experience uncontrollable and unpredictable seizures despite medication. Motor seizures, which manifest as repeated automatic movements and unconsciousness, is what most people think of when they hear the word ‘seizure’. ...
It is estimated that 1 in 100 people have epilepsy, and 1 in 3 people with epilepsy continue to experience uncontrollable and unpredictable seizures despite medication. Motor seizures, which manifest as repeated automatic movements and unconsciousness, is what most people think of when they hear the word ‘seizure’. ...
Using the SPEAC-recorded physiologic sEMG and audio data, physicians may quantify and qualify the types of seizure events their patients experience. Approximately one-third of people living with seizures report their anti-seizure medication (ASM) is not adequately controlling their episodes. Knowing the seizure ...